- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Age-related macular degeneration (AMD) affects the central part of the retina (called the macula) at the back of the eye. The wet form of AMD is caused by choroidal neovascularisation (the abnormal growth of blood vessels under the macula), from which fluid and blood can leak and cause swelling.
Showing all 3 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
-80°C |
2021.11 |
627,00 € |
||
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
-80°C |
2025.02 |
1.296,00 € |
||
VEGF-A |
Monoclonal Antibody |
Beovu® |
120 mg/mL |
– |
3 mg |
tba |
tba |
883,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany